Considered and approved the Un-Audited Financial Results for Quarter ended on 30th September 2021 as per Regulation 33(3) of the SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 along with the Limited Review Report.
12-Nov-2021
Download PDF
Mesco Pharmaceuticals
Considered and approved the Un-Audited Financial Results for Quarter ended on 30th September 2021 as per Regulation 33(3) of the SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 along with the Limited Review Report.